JAK inhibitors are typically used to suppress the immune system but have also been shown to enhance antitumour and antiviral immune responses. In this Perspective, Zak and Teijaro explore the basis of the immune-enhancing properties of JAK inhibitors and consider whether we can exploit these properties for cancer therapy.
- Jaroslav Zak
- John R. Teijaro
